
XGN
Healthcare · Diagnostics & Research · $105.4M market cap
$4.13-0.28 (-6.3%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -10.4% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 10, 2026 | Before the open | -0.19 | -0.25 | -31.6% |
| Aug 4, 2026 | Before the open | -0.19 | -0.13 | +31.6% |
| May 11, 2026 | Before the open | -0.25 | -0.20 | +20.0% |
| Mar 23, 2026 | Time not confirmed | -0.18 | -0.27 | -48.8% |
| Nov 4, 2025 | Before the open | -0.16 | -0.31 | -93.8% |
| Jul 29, 2025 | Before the open | -0.15 | -0.18 | -20.0% |
| May 5, 2025 | Before the open | -0.21 | -0.20 | +4.8% |
| Mar 17, 2025 | Before the open | -0.24 | -0.20 | +16.7% |
| Nov 12, 2024 | Before the open | -0.28 | -0.28 | 0.0% |
| Aug 5, 2024 | Before the open | -0.35 | -0.16 | +54.3% |
| May 13, 2024 | Before the open | -0.35 | -0.19 | +45.7% |
| Mar 18, 2024 | Before the open | -0.43 | -0.31 | +27.9% |
| Nov 13, 2023 | After the close | -0.49 |
Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of complex rheumatic, and autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company's lead testing product is…
| -0.31 |
| +36.7% |
| Aug 7, 2023 | Before the open | -0.49 | -0.28 | +42.9% |
| May 15, 2023 | After the close | -0.56 | -0.44 | +21.4% |
| Mar 20, 2023 | After the close | -0.78 | -0.83 | -6.4% |
| Nov 14, 2022 | After the close | -0.76 | -0.47 | +38.2% |
| Aug 4, 2022 | After the close | -0.57 | -0.78 | -36.8% |
| May 11, 2022 | After the close | -0.61 | -0.60 | +1.6% |
| Mar 22, 2022 | After the close | -0.50 | -0.42 | +16.0% |
| Nov 10, 2021 | After the close | -0.47 | -0.42 | +10.6% |
| Aug 9, 2021 | After the close | -0.44 | -0.38 | +13.6% |
| May 11, 2021 | After the close | -0.48 | -0.48 | 0.0% |
| Mar 16, 2021 | After the close | -0.41 | -0.27 | +34.1% |
| Nov 10, 2020 | After the close | -0.47 | -0.34 | +27.7% |
| Jul 28, 2020 | Before the open | -0.79 | -0.27 | +65.8% |
| May 11, 2020 | After the close | -0.56 | -0.44 | +21.4% |
| Mar 25, 2020 | After the close | -0.37 | -0.27 | +27.0% |
| Nov 12, 2019 | After the close | -2.40 | -11.29 | -370.4% |
| Sep 20, 2019 | After the close | 0.00 | -1.60 | — |